FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048152504> ?p ?o ?g. }

• W3048152504 endingPage "1427" @default.
• W3048152504 startingPage "1421" @default.
• W3048152504 abstract "Abstract As it has been shown that lopinavir (LPV) and hydroxychloroquine (HCQ) have in vitro activity against coronaviruses, they were used to treat COVID‐19 during the first wave of the epidemic in Lombardy, Italy. To compare the rate of clinical improvement between those who started LPV/ritonavir (LPV/r)+HCQ within 5 days of symptom onset (early treatment, ET) and those who started later (delayed treatment, DT). This was a retrospective intent‐to‐treat analysis of the hospitalized patients who started LPV/r + HCQ between 21 February and 20 March 2020. The association between the timing of treatment and the probability of 30‐day mortality was assessed using univariable and multivariable logistic models. The study involved 172 patients: 43 (25%) in the ET and 129 (75%) in the DT group. The rate of clinical improvement increased over time to 73.3% on day 30, without any significant difference between the two groups (Gray's test P = .213). After adjusting for potentially relevant clinical variables, there was no significant association between the timing of the start of treatment and the probability of 30‐day mortality (adjusted odds ratio [aOR] ET vs DT = 1.45, 95% confidence interval 0.50‐4.19). Eight percent of the patients discontinued the treatment becausebecause of severe gastrointestinal disorders attributable to LPV/r. The timing of the start of LPV/r + HCQ treatment does not seem to affect the clinical course of hospitalized patients with COVID‐19. Together with the severe adverse events attributable to LPV/r, this raises concerns about the benefit of using this combination to treat COVID‐19." @default.
• W3048152504 created "2020-08-13" @default.
• W3048152504 creator A5008126184 @default.
• W3048152504 creator A5010351936 @default.
• W3048152504 creator A5014801178 @default.
• W3048152504 creator A5016846891 @default.
• W3048152504 creator A5021535061 @default.
• W3048152504 creator A5026604925 @default.
• W3048152504 creator A5026873442 @default.
• W3048152504 creator A5040551171 @default.
• W3048152504 creator A5045504445 @default.
• W3048152504 creator A5055709893 @default.
• W3048152504 creator A5062449361 @default.
• W3048152504 creator A5062584952 @default.
• W3048152504 creator A5068011395 @default.
• W3048152504 creator A5072726581 @default.
• W3048152504 creator A5074089696 @default.
• W3048152504 creator A5081363212 @default.
• W3048152504 creator A5082761274 @default.
• W3048152504 creator A5083798648 @default.
• W3048152504 creator A5085833746 @default.
• W3048152504 creator A5088580718 @default.
• W3048152504 date "2020-09-28" @default.
• W3048152504 modified "2023-10-02" @default.
• W3048152504 title "Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS‐CoV‐2 infection: A retrospective cohort study" @default.
• W3048152504 cites W170188405 @default.
• W3048152504 cites W2017248106 @default.
• W3048152504 cites W2062932127 @default.
• W3048152504 cites W2106644744 @default.
• W3048152504 cites W2122256368 @default.
• W3048152504 cites W2150119943 @default.
• W3048152504 cites W2166189758 @default.
• W3048152504 cites W2332972182 @default.
• W3048152504 cites W2982073017 @default.
• W3048152504 cites W3001118548 @default.
• W3048152504 cites W3005212621 @default.
• W3048152504 cites W3007114958 @default.
• W3048152504 cites W3012379316 @default.
• W3048152504 cites W3012405893 @default.
• W3048152504 cites W3016154368 @default.
• W3048152504 cites W3018517500 @default.
• W3048152504 cites W3022402198 @default.
• W3048152504 cites W3023346879 @default.
• W3048152504 cites W3025704006 @default.
• W3048152504 cites W3026680813 @default.
• W3048152504 cites W3048152504 @default.
• W3048152504 doi "https://doi.org/10.1002/jmv.26407" @default.
• W3048152504 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7436522" @default.
• W3048152504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32776534" @default.
• W3048152504 hasPublicationYear "2020" @default.
• W3048152504 type Work @default.
• W3048152504 sameAs 3048152504 @default.
• W3048152504 citedByCount "22" @default.
• W3048152504 countsByYear W30481525042020 @default.
• W3048152504 countsByYear W30481525042021 @default.
• W3048152504 countsByYear W30481525042022 @default.
• W3048152504 countsByYear W30481525042023 @default.
• W3048152504 crossrefType "journal-article" @default.
• W3048152504 hasAuthorship W3048152504A5008126184 @default.
• W3048152504 hasAuthorship W3048152504A5010351936 @default.
• W3048152504 hasAuthorship W3048152504A5014801178 @default.
• W3048152504 hasAuthorship W3048152504A5016846891 @default.
• W3048152504 hasAuthorship W3048152504A5021535061 @default.
• W3048152504 hasAuthorship W3048152504A5026604925 @default.
• W3048152504 hasAuthorship W3048152504A5026873442 @default.
• W3048152504 hasAuthorship W3048152504A5040551171 @default.
• W3048152504 hasAuthorship W3048152504A5045504445 @default.
• W3048152504 hasAuthorship W3048152504A5055709893 @default.
• W3048152504 hasAuthorship W3048152504A5062449361 @default.
• W3048152504 hasAuthorship W3048152504A5062584952 @default.
• W3048152504 hasAuthorship W3048152504A5068011395 @default.
• W3048152504 hasAuthorship W3048152504A5072726581 @default.
• W3048152504 hasAuthorship W3048152504A5074089696 @default.
• W3048152504 hasAuthorship W3048152504A5081363212 @default.
• W3048152504 hasAuthorship W3048152504A5082761274 @default.
• W3048152504 hasAuthorship W3048152504A5083798648 @default.
• W3048152504 hasAuthorship W3048152504A5085833746 @default.
• W3048152504 hasAuthorship W3048152504A5088580718 @default.
• W3048152504 hasBestOaLocation W30481525041 @default.
• W3048152504 hasConcept C126322002 @default.
• W3048152504 hasConcept C142462285 @default.
• W3048152504 hasConcept C151956035 @default.
• W3048152504 hasConcept C156957248 @default.
• W3048152504 hasConcept C167135981 @default.
• W3048152504 hasConcept C197934379 @default.
• W3048152504 hasConcept C203014093 @default.
• W3048152504 hasConcept C2777182164 @default.
• W3048152504 hasConcept C2779123688 @default.
• W3048152504 hasConcept C2779134260 @default.
• W3048152504 hasConcept C2779298103 @default.
• W3048152504 hasConcept C2781392899 @default.
• W3048152504 hasConcept C2993143319 @default.
• W3048152504 hasConcept C3008058167 @default.
• W3048152504 hasConcept C3013748606 @default.
• W3048152504 hasConcept C44249647 @default.
• W3048152504 hasConcept C524204448 @default.
• W3048152504 hasConcept C71924100 @default.
• W3048152504 hasConceptScore W3048152504C126322002 @default.

• next